Verano Holdings VRNO
OTC VRNO
$6.21 +0.16 (+2.64%)
As of: Aug 21, 2026 · 3:59 PM EDT

Verano Holdings (VRNO) Cash from Investing Activities (2021 - 2026)

Verano Holdings (VRNO) posted quarterly Cash from Investing Activities of -$14.9 million for Q1 2026, down 212.45% year-over-year from $13.3 million in Q1 2025, and down 49.56% quarter-over-quarter from -$10.0 million in Q4 2025.

Verano Holdings (VRNO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has reported Cash from Investing Activities for 6 consecutive years, with -$14.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 212.45% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$42.7 million (up 66.7% YoY), while the FY2025 annual figure was -$32.6 million, up 75.53% from the prior year.
  • Cash from Investing Activities eased to -$14.9 million in Q1 2026 per VRNO's latest filing, from -$10.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$4.8 million in Q1 2025 and bottomed at -$92.6 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$24.9 million across 5 years, with a median of -$10.4 million in 2025.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 92.25% — and 2024, when it tumbled 830.65%.
  • Verano Holdings' Cash from Investing Activities stood at -$22.6 million in 2022, then soared by 56.45% to -$9.8 million in 2023, then dropped by 26.17% to -$12.4 million in 2024, then increased by 19.61% to -$10.0 million in 2025, then plunged by 49.56% to -$14.9 million in 2026.
  • Business Quant data shows VRNO's Cash from Investing Activities at -$14.9 million in Q1 2026, -$10.0 million in Q4 2025, and -$7.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Verano Holdings 449.04 Mn 363.85 Mn 99.70 Mn -11.85 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.85 Mn
Jun 30, 2026 -11.85 Mn
Mar 31, 2026 -14.91 Mn
Mar 31, 2026 -14.91 Mn
Dec 31, 2025 -9.97 Mn
Dec 31, 2025 -9.97 Mn
Sep 30, 2025 -7.45 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -10.41 Mn
Jun 30, 2025 -10.41 Mn
Mar 31, 2025 -4.77 Mn
Mar 31, 2025 -4.77 Mn
Dec 31, 2024 -12.40 Mn
Dec 31, 2024 -12.40 Mn
Sep 30, 2024 -92.64 Mn
Sep 30, 2024 -92.64 Mn
Jun 30, 2024 -18.52 Mn
Jun 30, 2024 -18.52 Mn
Mar 31, 2024 -9.70 Mn
Mar 31, 2024 -9.70 Mn